Physicians' Academy
for Cardiovascular Education
Agenda
Topics
▼
Media
▼
Online-CME
News
▼
Meeting Reports
Slides
▼
About
ACC 2020
▼
AHA 2020
▼
Covid-19
▼
Diabetes & CVD
▼
ESC 2020
▼
HF Practical Tutorials
▼
Kidney disease & CVD
▼
tes diab
Sep. 29, 2015
10 minute education • 27-9-2015 • Dr David Fitchett
SGLT2 inhibitor outcome trials: Future opportunities
Dr Fitchett discusses the unmet glycemic control needs, the ongoing clinical trials with SGLT2 inhibitors and the EMPA-REG OUTCOME trial
Share this page with your colleagues and friends:
Share this page with your colleagues and friends: